Murat Yalcinsoy

Murat Yalcinsoy

Auto-generated profile, based on publicly available information

Murat Yalcinsoy

Department of Pulmonary Diseases, İnönü University Faculty of Medicine, Malatya, Türkiye

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in International Immunopharmacology
Verified
Journal Article
Closed access
SGSinem Gungor
Sinem Gungor
FOFerhan Ozseker
Ferhan Ozseker
MYMurat Yalcinsoy
Murat Yalcinsoy
EAEsen Akkaya
Esen Akkaya
GCGünay Can
Günay Can
NGNilgün Sema Genc
Nilgün Sema Genc

1 January 2014 in Multidisciplinary Respiratory Medicine
Verified
Journal Article
Open access
PDF file
FKFeyza Kargin
Feyza Kargin
HTHuriye Berk Takir
Huriye Berk Takir
CSCuneyt Salturk
Cuneyt Salturk
NGNezihe C Goksenoglu
Nezihe C Goksenoglu
CKCan Y Karabay
Can Y Karabay
ZKZuhal Karakurt
Zuhal Karakurt
The safety of beta-blockers as a heart rate-limiting drug (HRLD) in patients with acute respiratory failure (ARF) due to chronic obstructive lung disease (COPD) has not been properly assessed in the intensive care unit (ICU) setting. This study aims to compare the use of beta-blocker drugs relative to non-beta-blocker ones in COPD patients with ARF due to heart rate-limiting with respect to length of ICU stay and mortality.

1 May 2016 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
MYMurat Yalcinsoy
Murat Yalcinsoy
CSCuneyt Salturk
Cuneyt Salturk
SOSelahattin Oztas
Selahattin Oztas
SGSinem Gungor
Sinem Gungor
IOIpek Ozmen
Ipek Ozmen
NANalan Adiguzel
Nalan Adiguzel
Purpose: Noninvasive mechanical ventilation (NIMV) usage outside of intensive care unit is not recommended in patients with COPD for severe acute respiratory failure (ARF). We assessed the factors associated with failure of NIMV in patients with ARF and severe acidosis admitted to the emergency department and followed on respiratory ward. Patients and methods: This is a retrospective observational cohort study conducted in a tertiary teaching hospital specialized in chest diseases and thoracic surgery between June 1, 2013 and May 31, 2014. COPD patients who were admitted to our emergency department due to ARF were included. Patients were grouped according to the severity of acidosis into two groups: group 1 (pH=7.20–7.25) and group 2 (pH=7.26–7.30). Results: Group 1 included 59 patients (mean age: 70±10 years, 30.5% female) and group 2 included 171 patients (mean age: 67±11 years, 28.7% female). On multivariable analysis, partial arterial oxygen pressure to the inspired fractionated oxygen (PaO2/FiO2) ratio <200, delta pH value <0.30, and pH value <7.31 on control arterial blood gas after NIMV in the emergency room and peak C-reactive protein were found to be the risk factors for NIMV failure in COPD patients with ARF in the ward. Conclusion: NIMV is effective not only in mild respiratory failure but also with severe forms of COPD patients presenting with severe exacerbation. The determination of the failure criteria of NIMV and the expertise of the team is critical for treatment success.

18 October 2018 in Turkish Thoracic Journal
Verified
Journal Article
Closed access
EAEmine Aksoy
Emine Aksoy
SGSinem Gungor
Sinem Gungor
MAMeltem Coban Agca
Meltem Coban Agca
IOIpek Ozmen
Ipek Ozmen
DDDildar Duman
Dildar Duman
ZKZuhal Karakurt
Zuhal Karakurt
Turkthoracj, Turkish Thoracic Journal

5 November 2015 in Wiener klinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
MYMurat Yalçınsoy
Murat Yalçınsoy
CSCuneyt Salturk
Cuneyt Salturk
HTHurıye Berk Takır
Hurıye Berk Takır
SKSemra Batı Kutlu
Semra Batı Kutlu
AOAyşegul Oguz
Ayşegul Oguz
ZKZuhal Karakurt
Zuhal Karakurt

1 November 2021 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
SBSumeyye Alparslan Bekir
Sumeyye Alparslan Bekir
MYMurat Yalcinsoy
Murat Yalcinsoy
SGSinem Gungor
Sinem Gungor
ETEylem Tunçay
Eylem Tunçay
FAFatma Tokgoz Akyil
Fatma Tokgoz Akyil
SBSibel Boga
Sibel Boga
This study aimed to evaluate the prognostic value of inflammatory markers determined during admission among patients with sarcoidosis with chronic and remission groups. This study was designed as retrospective single-center study. Patients with sarcoidosis without treatment and who had at least two years of follow-up were included in this study. Patients were divided into two groups as chronic and remission. The primary outcome is to evaluate hematological parameters in remission and chronic sarcoidosis groups. Out of 348 patients with sarcoidosis, 142 patients without treatment and followed up for at least two years were included in this study. Groups had similar demographic features with the predominance of females (80.4 and 77.9%, respectively) and stage I disease (78.6 and 68.6%, respectively). Lymphocyte count [median (IQR) 1.7 (1.3-2.3) 109/L versus 2.1 (1.6-2.4) 109/L, p=0.034] was significantly lower, whereas neutrophil to lymphocyte ratio (NLR) was significantly higher [median (IQR) 2.6 (2.0-3.1) versus 2.0 (1.6-2.8), p=0.006] at admission in the chronic group. No significant difference was determined in inflammatory parameters at admission between groups. Lower lymphocyte count and higher neutrophil to lymphocyte ratio were determined in patients with chronic sarcoidosis compared with the remission group, based on monitoring of radiological staging up to five-year after the initial diagnosis. Accordingly, the identification of neutrophil to lymphocyte ratio at diagnosis seems to be a potential prognostic marker in patients with sarcoidosis beside its low cost and easy determination in routine clinical practice.